In 2019, the spinal cord stimulation (SCS) segment accounted for more than 62% of the global neural implants market share. The growth of the segment has been fueled primarily due to the increasing prevalence of neuropathic pain, particularly the upsurge of patients with failed back surgery syndrome (FBSS)/failed back syndrome (FBS), and the attempts to use strategies other than chronic opioid therapy for the treatment of chronic neuropathic pain.
The chronic pain segment will cross USD 4 billion by 2025. According to the WHO, an estimated 22% of the world's primary care patients have chronic debilitating pain making chronic pain a global challenge to be addressed by healthcare professionals. The incidence/prevalence of chronic pain is increasing rapidly worldwide.
In 2019, hospitals' end-user segment constituted over 56% of the global neural implants market share. Healthcare professionals in hospitals are using neural implants for treating symptoms associated with neuropathic pain and neurodegenerative disorders. The industry is growing at a healthy rate and is likely to grow during the forecast period.
Neural Implants Market by Product
F&B Spinal Cord Stimulation (SCS)
Deep Brain Stimulation (DBS)
Vagus Nerve Stimulation (VNS)
Neural Implants Market by Application
Parkinson's Disease (PD)
Neural Implants Market by End-user
Specialized Neurological Centers (SNCs)
Outpatient Surgery Centers
Neural Implants Market – Dynamics
The growing demand for neural implants has encouraged several vendors to develop the latest generation technological platforms/devices to address the prevailing unmet needs in the treatment of neural disorders such as PD, epilepsy, chronic pain and other conditions. The brain implant technology has witnessed many technical advancements and improvements. Technological advancements in neural implant devices have revolutionized and enhanced the clinical outcome of treatment with SCS, DBS, and VNS systems. Since the first commercial appearance of neural implants, continuous innovation, and research has led the path for further evolution in this space. One of the most established clinical practices of neural implants includes DBS. The FDA first approved the use of DBS for essential tremor in 1997. Since then, the FDA or other global regulators have approved DBS for several indications, including PD, dystonia, epilepsy, and OCD.
Key Drivers and Trends fueling Market Growth:
Promising Investigational Devices
New Product Approvals/Launches
Rising Target Patient Pool Globally
Growing Popularity of MR-conditional Neural Implants
Neural Implants Market – Geography
North America dominated the neural implants market with the highest market share owing to the presence of a large proportion of the patient population, coupled with better access to treatment with the latest generation neural implants. The strong presence of key neural implants players is another factor contributing to the higher uptake of neural implants in North America. The rise in the number of PD, chronic pain, epilepsy, and other patient pool coupled with the necessity to treat the diseases with advanced procedures is expected to boost the market growth during the forecast period.
Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.